» Articles » PMID: 38769435

Transcriptional Control of Metabolism by Interferon Regulatory Factors

Overview
Specialty Endocrinology
Date 2024 May 20
PMID 38769435
Authors
Affiliations
Soon will be listed here.
Abstract

Interferon regulatory factors (IRFs) comprise a family of nine transcription factors in mammals. IRFs exert broad effects on almost all aspects of immunity but are best known for their role in the antiviral response. Over the past two decades, IRFs have been implicated in metabolic physiology and pathophysiology, partly as a result of their known functions in immune cells, but also because of direct actions in adipocytes, hepatocytes, myocytes and neurons. This Review focuses predominantly on IRF3 and IRF4, which have been the subject of the most intense investigation in this area. IRF3 is located in the cytosol and undergoes activation and nuclear translocation in response to various signals, including stimulation of Toll-like receptors, RIG-I-like receptors and the cGAS-STING pathways. IRF3 promotes weight gain, primarily by inhibiting adipose thermogenesis, and also induces inflammation and insulin resistance using both weight-dependent and weight-independent mechanisms. IRF4, meanwhile, is generally pro-thermogenic and anti-inflammatory and has profound effects on lipogenesis and lipolysis. Finally, new data are emerging on the role of other IRF family members in metabolic homeostasis. Taken together, data indicate that IRFs serve as critical yet underappreciated integrators of metabolic and inflammatory stress.

Citing Articles

Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications.

Fan M, Tian J, Chen T, Zhang C, Liu X, Zhao Z World J Diabetes. 2024; 15(10):2041-2057.

PMID: 39493568 PMC: 11525733. DOI: 10.4239/wjd.v15.i10.2041.


Epigenomic, cistromic, and transcriptomic profiling of primary kidney tubular cells.

Liu Z, Zhang L, Chen Y J Biol Methods. 2024; 11(2):e99010015.

PMID: 39323486 PMC: 11423943. DOI: 10.14440/jbm.2024.0009.

References
1.
Mikkelsen T, Xu Z, Zhang X, Wang L, Gimble J, Lander E . Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010; 143(1):156-69. PMC: 2950833. DOI: 10.1016/j.cell.2010.09.006. View

2.
Jefferies C . Regulating IRFs in IFN Driven Disease. Front Immunol. 2019; 10:325. PMC: 6449421. DOI: 10.3389/fimmu.2019.00325. View

3.
Lucchini F, Wueest S, Challa T, Item F, Modica S, Borsigova M . ASK1 inhibits browning of white adipose tissue in obesity. Nat Commun. 2020; 11(1):1642. PMC: 7118089. DOI: 10.1038/s41467-020-15483-7. View

4.
Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

5.
Otero Y, Mulligan K, Barnes T, Ford E, Malabanan C, Zong H . Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin-Stimulated Muscle Glucose Uptake. Shock. 2015; 45(6):677-85. PMC: 4868638. DOI: 10.1097/SHK.0000000000000550. View